✦ LIBER ✦

The cellular and molecular basis of the Lyt-1+2− T cell-mediated tumor-eradicating mechanism in vivo

✍ Scribed by Hiromi Fujiwara; Toshiyuki Hamaoka

Publisher: John Wiley and Sons
Year: 1986
Tongue: English
Weight: 628 KB
Volume: 4
Category: Article
ISSN: 0265-9247
DOI: 10.1002/bies.950040106

No coin nor oath required. For personal study only.

✦ Synopsis

Inhibition of mixed-function oxidations by substrates forming reduced cytochrome P-450 metabolic-intermediate complexes. Pharmac. Ther. 14 SOGAWA, K., GOTOH, O., KAWAJIRI, K. & FUJI-KURIYAMA, Y. (1984). Distinct organization of methylcholanthrene-and phenobarbital-inducible cytochrome P-450 genes in the rat. Proc. Natl. Acad. Sci. USA 81, 50665070.

📜 SIMILAR VOLUMES

In vivo splenic irradiation eradicates s

In vivo splenic irradiation eradicates suppressor T-cells causing the regression and inhibition of established tumor

✍ Warren E. Enker; Janet L. Jacobitz 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 French ⚖ 625 KB

## Abstract Splenic irradiation has been employed in tumor‐bearing animals to eradicate non‐specific, spleen‐seeking suppressor T cells, and to inhibit established tumor growth. MC1315 tumor‐bearing BALB/c mice were treated with 400 R splenic irradiation. Untreated mice or mice receiving 400 R sple

Generation of effector cells from T cell

Generation of effector cells from T cell subsets III. Synergy between Lyt-1 and Lyt-123/23 lymphocytes in the generation of H-2-restricted and alloreactive cytotoxid T cells

✍ Markus M. Simon; Andrew J. Edwards; Ulrich Hämmerling; Ian F. C. McKenzie; Klaus 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 487 KB

Alternative production of Bcl-2 and Bax

Alternative production of Bcl-2 and Bax by tumor cells determines the rates of in vivo tumor progression: Suggested mechanisms

✍ Galina I. Deichman; Natalya A. Dyakova; Valentina A. Matveeva; Lydia M. Kashkina 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB

## Abstract The hypothesis tested in the study suggests that mechanisms of the earlier described delayed or accelerated tumor progression may be regulated by the antiapoptotic and proapoptotic cellular programs activated in stress reactions of transformed cells to the host normal cellular environme

Cell-mediated anti-tumor response in the

Cell-mediated anti-tumor response in the RL♂ 1 system I. T nature, H-2 Dd involvement and antigenic specificity of the effector cells

✍ Veronique Duprez; Elisabeth Gomard; J. P. Levy 📂 Article 📅 1978 🏛 John Wiley and Sons 🌐 English ⚖ 582 KB

CD4+ T cell-mediated HER-2/neu-specific

CD4+ T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells

✍ Jan Alvar Lindencrona; Susanne Preiss; Thomas Kammertoens; Thomas Schüler; Marie 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 134 KB

## Abstract HER‐2/neu (HER‐2) is a cell surface proto‐oncogene that is often overexpressed in carcinomas. Passive administration of anti‐HER‐2 antibodies in breast cancer patients has achieved promising results, but less is known about the role of antibodies in active immunization. We asked whether

Cyclic AMP mediated GSTP1 gene activatio

Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: A novel mechanism of cellular GSTP1 gene regulation

✍ Hui-Wen Lo; Francis Ali-Osman 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 1 views

The human GSTP1 gene is frequently over-expressed in many human cancers and the expression increases with tumor progression and is associated with a more aggressive biology, poor patient survival, and resistance to therapy. The molecular regulation of the human GSTP1 gene during malignancy is, howev